Cantabio Pharmaceuticals
PrivateLast Round
Grant
Feb 6, 2024
Total Funding Raised
$600,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cantabio Pharmaceuticals operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Grant round in February 2024.
Cantabio Pharmaceuticals is a biotechnology company that develops novel disease-modifying therapeutics and diagnostics for neurodegenerative and metabolic conditions such as Parkinson's and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantabio Pharmaceuticals Comparables
Compare Cantabio Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Origami Therapeutics | 87% | |
| Amathus Therapeutics | 85% | |
| Retromer Therapeutics | 82% |
For institutional investors. Book with your work email.
Cantabio Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 6, 2024 | ||||
| Grant | Aug 17, 2023 | ||||
| Grant | Sep 2, 2020 | ||||
| Convertible Debt | Feb 2, 2017 | ||||
| Private Placement | Oct 21, 2015 |
For institutional investors. Book with your work email.
Cantabio Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Yorkville Advisors | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 48% MoM.
- Apr 24, 2026
Monthly visitors increased 48% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Cantabio Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cantabio Pharmaceuticals's valuation, stock price, and market status.
Is Cantabio Pharmaceuticals a public or private company?
Cantabio Pharmaceuticals is a private company.
What is the current stock price of Cantabio Pharmaceuticals?
Cantabio Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Cantabio Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cantabio Pharmaceuticals worth (valuation)?
Valuation information for Cantabio Pharmaceuticals is not publicly available.
Can I buy Cantabio Pharmaceuticals stock?
Cantabio Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cantabio Pharmaceuticals's last funding round?
Cantabio Pharmaceuticals's most recent funding round was Grant on February 6, 2024.
Who are the main investors in Cantabio Pharmaceuticals?
Key investors in Cantabio Pharmaceuticals include The Michael J. Fox Foundation for Parkinson's Research, Yorkville Advisors.
Will Cantabio Pharmaceuticals IPO soon?
No public IPO plans have been announced for Cantabio Pharmaceuticals.
How can I track Cantabio Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Cantabio Pharmaceuticals's shares on secondary markets.